High-dose cyclophosphamide and VP 16 as
โ
David Cunningham; Stephen W. Banham; Andrew H. Hutcheon; Alistair Dorward; Salim
๐
Article
๐
1985
๐
Springer
๐
English
โ 400 KB
This study investigated the use of late dose intensification therapy (LDIT) with cyclophosphamide (180 mg/kg) and VP 16 (1 g/m2) plus autologous bone marrow rescue in 22 patients with small cell lung cancer (SCLC). These patients were selected from a group of 95 patients who received three courses o